Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Dynamics of circulating microparticles in liver transplant patients.

Brodsky SV, Facciuto ME, Heydt D, Chen J, Islam HK, Kajstura M, Ramaswamy G, Aguero-Rosenfeld M.

J Gastrointestin Liver Dis. 2008 Sep;17(3):261-8.

2.

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.

Ann Surg Oncol. 2000 Dec;7(10):764-70.

PMID:
11129425
3.

Circulating platelet-derived endothelial cell growth factor increases in hepatocellular carcinoma patients.

Jin-no K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Endo H, Doi T, Mandai K, Ishitsuka H.

Cancer. 1998 Apr 1;82(7):1260-7.

PMID:
9529017
4.

Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant.

Min AD, Saxena R, Thung SN, Atillasoy EO, Wolf DC, Sauter B, Schwartz ME, Bodenheimer HC Jr.

Am J Gastroenterol. 1998 Nov;93(11):2148-53.

PMID:
9820388
5.

Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis.

Garcia S, Chirinos J, Jimenez J, Del Carpio Muñoz F, Canoniero M, Jy W, Jimenez J, Horstman L, Ahn Y.

J Heart Lung Transplant. 2005 Dec;24(12):2184-9.

PMID:
16364869
6.

Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma.

Jinno K, Tanimizu M, Hyodo I, Nishikawa Y, Hosokawa Y, Doi T, Endo H, Yamashita T, Okada Y.

J Gastroenterol. 1998 Jun;33(3):376-82.

PMID:
9658317
7.

A panel of molecular markers in hepatitis C virus-related hepatocellular carcinoma.

Elgendy SM, Hessien M, Elsherbiny MM, Abd El-Salam IM, El-Attar IA, El-Asser Ael-B.

J Egypt Natl Canc Inst. 2005 Dec;17(4):270-8.

8.

Circulating microparticles and procoagulant activity in elderly patients.

Forest A, Pautas E, Ray P, Bonnet D, Verny M, Amabile N, Boulanger C, Riou B, Tedgui A, Mallat Z, Boddaert J.

J Gerontol A Biol Sci Med Sci. 2010 Apr;65(4):414-20. doi: 10.1093/gerona/glp187.

PMID:
19942591
9.

Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.

Cervello M, Virruso L, Lipani G, Giannitrapani L, Soresi M, Carroccio A, Gambino R, Sanfililippo R, Marasà L, Montalto G.

J Cancer Res Clin Oncol. 2000 Jun;126(6):345-51.

PMID:
10870645
10.

Hepatitis C and hepatocellular carcinoma.

Yao F, Terrault N.

Curr Treat Options Oncol. 2001 Dec;2(6):473-83. Review.

PMID:
12057093
11.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x.

PMID:
18422961
12.

Significance of circulating endothelial progenitor cells in hepatocellular carcinoma.

Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT.

Hepatology. 2006 Oct;44(4):836-43.

PMID:
17006919
13.

Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis.

Tarao K, Rino Y, Takemiya S, Ohkawa S, Sugimasa Y, Miyakawa K, Tamai S, Masaki T, Hirokawa S, Kameda Y, Nagaoka T, Okamoto N, Kokubu S, Yoshida M, Kakita A.

Cancer Sci. 2003 Dec;94(12):1083-90.

14.

Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.

Sieghart W, Fellner S, Reiberger T, Ulbrich G, Ferlitsch A, Wacheck V, Peck-Radosavljevic M.

Dig Liver Dis. 2009 Dec;41(12):902-6. doi: 10.1016/j.dld.2009.04.013.

PMID:
19501032
15.

Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection.

Shimizu I, Inoue H, Yano M, Shinomiya H, Wada S, Tsuji Y, Tsutsui A, Okamura S, Shibata H, Ito S.

Liver. 2001 Oct;21(5):342-9.

PMID:
11589771
16.

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.

Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.

Liver Transpl. 2004 Dec;10(12):1478-86.

17.

Diagnostic role of endothelial microparticles in vasculitis.

Erdbruegger U, Grossheim M, Hertel B, Wyss K, Kirsch T, Woywodt A, Haller H, Haubitz M.

Rheumatology (Oxford). 2008 Dec;47(12):1820-5. doi: 10.1093/rheumatology/ken373.

18.

Serum levels of circulating intercellular adhesion molecule 1 in hepatocellular carcinoma.

Hamazaki K, Gochi A, Shimamura H, Kaihara A, Maruo Y, Doi Y, Orita K, Lygidakis NJ.

Hepatogastroenterology. 1996 Jan-Feb;43(7):229-34.

PMID:
8682469
19.

Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

Tarao K, Takemiya S, Tamai S, Sugimasa Y, Ohkawa S, Akaike M, Tanabe H, Shimizu A, Yoshida M, Kakita A.

Cancer. 1997 Feb 15;79(4):688-94.

PMID:
9024706
Items per page

Supplemental Content

Support Center